November 1 marks the celebration of Diwali, a new year's festival and one of the most popular holidays in South Asia. Diwali is also sometimes referred to as “Deepavali,” which means "rows of lighted lamps." The lamps, or diyas, are often used to decorate houses, shops and public places. We had a wonderful time celebrating Diwali this week at our Cambridge offices. #Diwali #AlkeusPharma
Alkeus Pharmaceuticals, Inc.
Biotechnology Research
Cambridge, MA 6,959 followers
Transformation in Sight
About us
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
- Website
-
http://www.alkeuspharma.com
External link for Alkeus Pharmaceuticals, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Biopharmaceuticals, Rare Disease, Inherited Retinal Disorders, Genetic Diseases, Retina, and Ophthalmology
Locations
-
.
Cambridge, MA, US
Employees at Alkeus Pharmaceuticals, Inc.
Updates
-
We are thrilled to announce that accomplished biopharma industry executive David Arkowitz, MBA, has joined Alkeus as Chief Financial Officer. https://lnkd.in/emXXYjd6 #AlkeusPharma #biotechnews #Stargardt #CFO
-
Alkeus Pharmaceuticals, Inc. reposted this
“One of the first things patients lose in macular degeneration is low light vision, which can have a dramatic impact on daily living. The positive effect demonstrated on low luminance visual acuity (LLVA) is significant. Based on these results, this therapy would definitely have a place in the overall strategy of treating AMD and slowing the decline observed in our patients. The favorable safety profile could warrant treatment as early as possible.”
-
We recently had the pleasure of speaking with Renee and Mike, parents of Miles, an amazingly talented musician living with Stargardt disease. Their inspiring story is now live on the YourNorthStarg.com website. We are honored to have the opportunity to share their #Stargardt experience with you. Julia Carpenter-Conlin MSW, Paula Pearson https://lnkd.in/eaUgDBKG #YourNorthStarg #Stargardt #AlkeusPharma #patientvoices #blindnessawarenessmonth
-
We're #hiring a new Director, Clinical Data Management in Cambridge, Massachusetts. Apply today or share this post with your network.
-
Alkeus Pharmaceuticals, Inc. reposted this
The top 10 takeaways from AAO 2024: This year’s conference in Chicago showcased a diverse array of practice-changing data across multiple ophthalmic specialties, including advances in cataract surgery, glaucoma management, and retinal disease treatments. Read More: https://lnkd.in/eh-gckP5
-
Topline results from the clinical study of our investigational oral therapy for the potential treatment of geographic atrophy were presented at the AAO 2024 annual meeting in Chicago. Read today's press release here: https://lnkd.in/gWShQPBd #alkeuspharma #geographicatrophy #AAO2024 #biotechnews #Stargardt
-
We are having an amazing time at #AAO2024.
We had a great time at #AAO2024 today in Chicago. If you are attending the conference, stop by booth #1528 to hear about our clinical advancements. Birva Kadakia Shah O.D., Debbie Elizabeth Etchison, Aria Cohen, and Julia Carpenter-Conlin MSW. #alkeuspharma #YourNorthStarg #stargardt
-
We had a great time at #AAO2024 today in Chicago. If you are attending the conference, stop by booth #1528 to hear about our clinical advancements. Birva Kadakia Shah O.D., Debbie Elizabeth Etchison, Aria Cohen, and Julia Carpenter-Conlin MSW. #alkeuspharma #YourNorthStarg #stargardt
-
We are excited to be at #AAO2024. If you are in Chicago, visit us at booth 1528 to learn more about our work as we strive to make a difference in the lives of those living with retinal diseases. Paula Pearson, Birva Shah, Julia Carpenter-Conlin MSW #AlkeusPharma #Stargardt #geographicatrophy